Search Results - G. V. Mokrov

Refine Results
  1. 1
    Сardioprotective agents with biaromatic structure. Part 1. Calcium channel blockers

    Сardioprotective agents with biaromatic structure. Part 1. Calcium channel blockers by G. V. Mokrov

    Published 2022-02-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Сardioprotective agents with biaromatic structure. Part 4. Potassium hERG channels blockers and modulators

    Сardioprotective agents with biaromatic structure. Part 4. Potassium hERG channels blockers and modulators by G. V. Mokrov

    Published 2023-01-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Сardioprotective agents with biaromatic structure. Part 2. HCN channel blockers

    Сardioprotective agents with biaromatic structure. Part 2. HCN channel blockers by G. V. Mokrov

    Published 2022-07-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Сardioprotective agents with biaromatic structure. Part 5. Potassium Kv1.5-channels blockers

    Сardioprotective agents with biaromatic structure. Part 5. Potassium Kv1.5-channels blockers by G. V. Mokrov

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers

    Сardioprotective agents with biaromatic structure. Part 3. Sodium channel blockers by G. V. Mokrov

    Published 2022-12-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    Сardioprotective agents with biaromatic structure. Part 6. Beta blockers

    Сardioprotective agents with biaromatic structure. Part 6. Beta blockers by G. V. Mokrov

    Published 2023-11-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    Determination of the composition of pharmaceutical substances used in drugs with antiarrhythmic activity

    Determination of the composition of pharmaceutical substances used in drugs with antiarrhythmic activity by A. V. Rogov, G. V. Mokrov

    Published 2024-01-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    Epac signaling protein ligands as tools for studying their biological activity and creating new original drugs

    Epac signaling protein ligands as tools for studying their biological activity and creating new original drugs by G. V. Mokrov, T. D. Nikiforova, S. A. Kryzhanovskiy

    Published 2020-04-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Matrix metalloproteinases and their inhibitors

    Matrix metalloproteinases and their inhibitors by O. S. Grigorkevich, G. V. Mokrov, L. Yu. Kosova

    Published 2019-02-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Approaches to predict ligands affinity towards translocator protein TSPO 18 kDa in order to create molecules possessing neuropsychotropic activity

    Approaches to predict ligands affinity towards translocator protein TSPO 18 kDa in order to create molecules possessing neuropsychotropic activity by N. M. Baraboshkin, A. S. Pantileev, G. V. Mokrov

    Published 2019-01-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Translocator protein TSPO 18 kDa and its ligands: a promising approach to the creation of new neuropsychotropic drug

    Translocator protein TSPO 18 kDa and its ligands: a promising approach to the creation of new neuropsychotropic drug by G. V. Mokrov, O. A. Deeva, M. A. Yarkova, T. A. Gudasheva, S. B. Seredenin

    Published 2018-11-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Antidepressant activity of the pyrrolo[1,2a][1,4]diazepine GMAL-24 in a forced swimming test in mice

    Antidepressant activity of the pyrrolo[1,2a][1,4]diazepine GMAL-24 in a forced swimming test in mice by A. O. Korolev, A. V. Volkova, Ya. S. Kozin, G. V. Mokrov, T. A. Voronina, T. S. Kalinina

    Published 2023-11-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    Analysis of original bis-arylazaazkanes derivatives compliance with the calculated pharmacophoric models of biaromatic ligands of cardioprotective drugs biotargets

    Analysis of original bis-arylazaazkanes derivatives compliance with the calculated pharmacophoric models of biaromatic ligands of cardioprotective drugs biotargets by G. V. Mokrov, A. S. Pantileev, T. Yu. Vorobieva, V. E. Biryukova, S. A. Kryzhanovskii, V. L. Dorofeev

    Published 2024-06-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    Cardioprotective effects of compound ALM-802 on subendocardial ischemia models

    Cardioprotective effects of compound ALM-802 on subendocardial ischemia models by I. B. Tsorin, V. V. Barchukov, M. B. Vititnova, A. M. Likhosherstov, G. V. Mokrov, S. A. Kryzhanovskii

    Published 2021-09-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    A comparative study of the anti-ischemic activity of trimetazidine and the compound ALM-802 under conditions of endothelial dysfunction

    A comparative study of the anti-ischemic activity of trimetazidine and the compound ALM-802 under conditions of endothelial dysfunction by V. V. Barchukov, I. B. Tsorin, A. M. Likhosherstov, M. B. Vititnova, G. V. Mokrov, S. A. Kryzhanovskii

    Published 2019-02-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Novel 4-benzoylpyridine oxime derivative GIZH-298 with aticonvulsant activity

    Novel 4-benzoylpyridine oxime derivative GIZH-298 with aticonvulsant activity by L. A. Zhmurenko, G. V. Mokrov, L. N. Nerobkova, S. A. Litvinova, I. O. Gaydukov, T. A. Voronina, T. A. Gudasheva

    Published 2017-02-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    Screening of the compounds having cardiotropic activity among the α, ω-diarilmetil derivatives of bis-(ω-aminoalkyl)amines

    Screening of the compounds having cardiotropic activity among the α, ω-diarilmetil derivatives of bis-(ω-aminoalkyl)amines by S. A. Kryzhanovskii, A. M. Likhosherstov, I. B. Tsorin, V. N. Stolyaruk, M. B. Vititnova, G. V. Mokrov, T. A. Gudasheva

    Published 2016-03-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    4-BENZOYLPYRIDINE OXIME DERIVATIVE (GIZH-298) VERSUS VALPROIC ACID: THE ANTICONVULSANT POTENTIAL EFFECT IN A MODEL OF EPILEPSY IN RATS WITH COBALT-INDUCED LESIONS

    4-BENZOYLPYRIDINE OXIME DERIVATIVE (GIZH-298) VERSUS VALPROIC ACID: THE ANTICONVULSANT POTENTIAL EFFECT IN A MODEL OF EPILEPSY IN RATS WITH COBALT-INDUCED LESIONS by I. O. Gaydukov, S. A. Litvinova, T. A. Voronina, L. N. Nerobkova, L. A. Zhmurenko, G. V. Mokrov, G. G. Avakyan, I. S. Kutepova

    Published 2017-08-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    Search selective blockers of the zinc-dependent metalloproteinases 2nd and 9th type among the benzoylamino (phenylsulfonyl) amino-substituted cyclic aminoacids derivatives

    Search selective blockers of the zinc-dependent metalloproteinases 2nd and 9th type among the benzoylamino (phenylsulfonyl) amino-substituted cyclic aminoacids derivatives by S. A. Kryzhanovskii, G. V. Mokrov, O. S. Grigorkevich, I. B. Tsorin, V. N. Stolyaruk, M. B. Vititnova, A. M. Likhosherstov, T. A. Gudasheva

    Published 2016-09-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Study of ALM-802 orto-alkoxi analogues cardiotropic activity

    Study of ALM-802 orto-alkoxi analogues cardiotropic activity by G. V. Mokrov, A. M. Likhosherstov, V. V. Barchukov, V. N. Stolyaruk, I. B. Tsorin, M. B. Vititnova, S. A. Kryzhanovskiy, T. A. Gudasheva

    Published 2020-04-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: